11
38
Growth Score
-5 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
349571
Adapsyn is developing a bioinformatics platform devoted to discovering previously unidentified natural product drug candidates.
- Kelly Holman: Co-Founder and Managing DirectorPast Role: MDS Capital, Senior Investment Manager
- Nathan Magarvey: Founder and Chief Scientific Officer
About the Company
Adapsyn Bioscience is a owner and operator of a biotechnology company intended to focus on the identification and characterization of microorganism-derived small molecules, to uncover chemical agents possessing novel biological activities relevant to the biotechnology and pharmaceutical sectors. The company's services is supported by
cutting-edge bioinformatic software platforms and state of the art laboratory facilities, enabling researchers to drive the discovery of a diversified portfolio of drugs, thereby expediting the search for medicines that will better protect users from a wide spectrum of diseases.
